Episode Details
Back to Episodes
Episode 157: ASCO GU 2022 Sasatuzimab and pembrolizumab in bladder cancer
Season 1
Episode 157
Published 4 years, 8 months ago
Description
Petros Grivas describes the results of this phase 2 trial.